Trials / Completed
CompletedNCT00573768
Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain
A Randomized, Double-blind, Multi-center, Vehicle-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Applied Once or Twice Daily in Patients With Acute Ankle Sprain
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 271 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the efficacy of diclofenac diethylamine 2.32% gel in the treatment of acute ankle sprain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diclofenac diethylamine 2.32% gel | Diclofenac diethylamine 2.32% gel twice daily |
| DRUG | Placebo | Vehicle 2 times daily |
| DRUG | Diclofenac diethylamine 2.32% gel / Placebo | Diclofenac diethylamine 2.32% gel once daily / Vehicle once daily |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2007-12-01
- Completion
- 2008-07-01
- First posted
- 2007-12-14
- Last updated
- 2012-04-20
- Results posted
- 2010-11-18
Locations
29 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00573768. Inclusion in this directory is not an endorsement.